Key result
Ischemic preconditioning cuts late-phase infarct size ~43% in wild-type mice, dependent on HSP70.
Answers are grounded in this paper and cite their sources.
We investigated the role of inducible heat shock proteins 70.1 and 70.3 (HSP70.1 and HSP70.3, respectively) in myocardial ischemic preconditioning (IP) in mice. Wild-type (WT) mice and HSP70.1- and HSP70.3-null [HSP70.1/3(-/-)] mice were subjected to IP and examined 24 h later during the late phase of protection. IP significantly increased steady-state levels of HSP70.1 and HSP70.3 mRNA and expression of inducible HSP70 protein in WT myocardium. To assess protection against tissue injury, mice were subjected to 30 min of regional ischemia and 3 h of reperfusion. In WT mice, IP reduced infarct size by 43% compared with sham IP-treated mice. In contrast, IP did not reduce infarct size in HSP70.1/3(-/-) mice. Absence of inducible HSP70.1 and HSP70.3 had no effect, however, on classical or early-phase protection produced by IP, which significantly reduced infarct size in HSP70.1/3(-/-) mice. We conclude that inducible HSP70.1 and HSP70.3 are required for late-phase protection against infarction following IP in mice.
No takes yet. Share an insight, caveat, or question.
Hampton et al. (2003) studied Myocardial ischemia-reperfusion injury. Ischemic preconditioning (IP) in wild-type vs HSP70.1/3(-/-) mice vs. Sham ischemic preconditioning was evaluated on Myocardial infarct size (43% reduction in WT mice; no reduction in HSP70.1/3(-/-) mice). Ischemic preconditioning reduced myocardial infarct size by 43% during the late phase in wild-type mice compared with sham, whereas it did not reduce infarct size in HSP70.1/3(-/-) mice.
Synapse has enriched 10 related papers. Consider them for comparative context: